The revelation that a major drugmaker is cutting production at its Quebec plant has ramped up fears among doctors and patients about a critical shortage of injectable medicines nationwide.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
